Riskpilot← Back to searchSign inGet full accessLäkare Osama AB
ABActiveOrg 5568454390Sergeantgatan 38Medical specialists activities · NACE 8622Est. 20112 employees
Revenue 2024
SEK 3,7M
+3% vs 2023
EBITDA margin
33.5%
+2% vs 2023
Equity ratio
75.2%
Financial strength
Net profit 2024
SEK 1,6M
+41% vs 2023
| Revenue | SEK 3,7M | +3% |
| EBITDA | SEK 1,2M | +2% |
| Net profit | SEK 1,6M | +41% |
| Total assets | SEK 9,9M | +25% |
| Equity | SEK 7,5M | +21% |
| Employees | 2 | — |
Legal name
Läkare Osama AB
Org number
5568454390
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 mars 2011
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva läkarverksamhet jämte därmed förenlig verksamhet.
Address
Sergeantgatan 38
Email
orayes@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 469 | 3 508 | 3 359 | 3 565 | 3 659 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 120 | 1 585 | 1 338 | 1 203 | 1 224 |
| Depreciation & amort. | −0 | −0 | −4 | −8 | −8 |
| EBIT | 1 120 | 1 585 | 1 334 | 1 195 | 1 216 |
| Net financials | −3 | −2 | — | 84 | 1 322 |
| Profit before tax | 1 267 | 1 213 | 1 034 | 1 459 | 2 037 |
| Tax | −302 | −253 | −215 | −315 | −428 |
| Net profit | 965 | 960 | 819 | 1 144 | 1 609 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 753 | 6 740 | 7 339 | 7 926 | 9 915 |
| Equity | 4 119 | 4 779 | 5 299 | 6 143 | 7 452 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 504 | 460 | 240 | 163 | 343 |
| Total debt | 504 | 460 | 240 | 163 | 343 |
EBITDA margin
33.5%
This company
15.8%
Market median
+112% vs market
20202024
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
20202024
Return on equity
21.6%
This company
18.4%
Market median
+17% vs market
20202024
Net profit margin
44.0%
This company
8.1%
Market median
+443% vs market
20202024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UT Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Läkare Osama AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Thomas Appelgren | Audit | 0 companies |
| Etaf Fawzi El Rayyes | Deputy Board Member | 0 companies |
| Osama Ibrahim Mohamed Al Rayyes | Board of Directors | 0 companies |